Indian drug makers are targeting the North American market.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Indian drug makers are targeting the North American market.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- India supplies 40 per cent of generic drugs consumed in the US, with government programs like Medicare procuring these drugs to cut expenditure, though tariff hikes pose a threat.Sub-event
Indian drug makers are expanding their focus to the North American market.1 source
Keep exploring
Part of
The generic drug market is seeing significant growth, driven by Indian firms and regional markets, with major players like Aurobindo, J&J, and GSK involved.Also in this story
- BMY intended to expand manufacturing capacity in Europe and Japan, with Reuters reporting the decision.
- Arosi's successful launch and aggressive pricing from generic competition are impacting the pharmaceutical market.
The entities involved
-
North America
continent in the Americas